|
Almeida Capital is pleased to be a premier sponsor of AltAssets
|
FREE newsletter RSS
INTELLIGENCE
RECRUITMENT
KNOWLEDGE BANK
EVENTS
SECTOR ANALYSIS
HEDGE FUNDS
|
Click here for printer friendly page
Life sciences expert Dr David Sinclair joins Lux Capital as venture partner20/12/2007. Source: AltAssets. 
 US venture capital firm Lux Capital Management has appointed Dr David Sinclair as a venture partner. Dr Sinclair is a co-founder of both Sirtris Pharmaceuticals and Genocea Biosciences.
He is also Associate Professor of pathology at Harvard Medical School and director of the Glenn Laboratories for the Biological Mechanisms of Aging.
'David is not only one of the most published scientists in the field of biology, but also an experienced serial entrepreneur,' said Robert Paull, managing general partner at Lux Capital. 'His addition to the Lux Capital team strengthens our life sciences investment initiatives and expands our presence in the Northeast.'
Lux Capital focuses on investments in the physical and life sciences.
Copyright © 2007 AltAssets
|
 
|
|
|
